Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Apr9g1295 ATGACTCTGTCTTCATCTGTTCCACTCTGCATGCTTCTCTTCTCATTCATTTTCTTCTTCACTTGCTCCTCTACCAAACTTAATCATGATAGTAAAAACGACTCTCTTTCCCTCTCTTTCCCTCTAACGTTCTTTCCACTCACCAGAGAGAAACCACTTAAGAACAACCCTCAACAGAGAACCCTTTCTTCCTCTTCTTCGTCATCATCATCGTACAACGTGAAATCTTCATTCAAGTACTCCATGGCTCTGGTTGTTACGCTTCCGATAGGTACTCCACCGCAGCTTCAACAAATGGTGTTGGACACGGGAAGCCAACTCTCATGGATTCAGTGTCACAACAAGAAAACACCTCCTAAGACGGCGTTTAATCCTTCTCTCTCTTCTTCTTTCTATGTCCTCCCTTGCACCCACCCTCTTTGCAAACCACGCGTTCCCGATTTTACCCTTCCCACAACCTGCGACCAGAACCGCCTCTGCCACTACTCCTACTTCTACGCCGACGGCACTTACGCCGAGGGCAATCTCGTCCGGGAAAAACTCACTTTCTCCTCTTCCCAAACTACCCCTCCACTTATCCTCGGCTGCGCTACTGAATCCAGCGACGCCAGGGGCATTTTGGGAATGAACCTCGGTCGCTTGTCTTTCCCCTCTCAAGCCAAAATTACCAAATTCTCCTATTGTGTCCCCGCCCGTCAAACCCGACCCGGAACTATCCCAACTGGGTCGTTCTACCTCGGAAACAACCCGGCTTCGTCACGGTTCCGTTACGTTAACATGTTGACCTTTGGTCAAAGTCATCGTATGCCGAATTTGGACCCCTTAGCCTACACTCTCCCAATGCAAGGAATTAAAATCAACGGCAAAAGACTGAACATCCAGCCTTCGGTTTTCAGGCCCAACGCTGGCGGGTCGGGCCAGACCATGATTGATTCCGGATCCGAATTCACGTTTTTGGTGGACGAGGCTTACGGTAAAGTGCGGGAGGAAATAGAGAGAGTGGTGGGACCCAAATTGAAGAAGGGGTACGTGTACGGTGGAGTTTCTGACATGTGTTTTGATGGTGATGCGATGGAGATCGGACGGTTGGTAGGGGACGTAGTTTTCGAGTTCGAGAAGGGCGTGGAGATTGTGATTCGGAAAGAGAGGGTGCTTGCAGACGTGGGCGGTGGGGTCCACTGCGTGGGAATCGGAAGGTCAGAAAGATTGGGTGCGGCGAGTAACATTATTGGCAACTTCCATCAGCAGAATCTCTGGGTGGAGTTTGATCTGGCCAATCGTAGAGTGGGATTCGGTGAGGCTGATTGTAGCAGATCCATAAACTAA 1326 0.4992 MTLSSSVPLCMLLFSFIFFFTCSSTKLNHDSKNDSLSLSFPLTFFPLTREKPLKNNPQQRTLSSSSSSSSSYNVKSSFKYSMALVVTLPIGTPPQLQQMVLDTGSQLSWIQCHNKKTPPKTAFNPSLSSSFYVLPCTHPLCKPRVPDFTLPTTCDQNRLCHYSYFYADGTYAEGNLVREKLTFSSSQTTPPLILGCATESSDARGILGMNLGRLSFPSQAKITKFSYCVPARQTRPGTIPTGSFYLGNNPASSRFRYVNMLTFGQSHRMPNLDPLAYTLPMQGIKINGKRLNIQPSVFRPNAGGSGQTMIDSGSEFTFLVDEAYGKVREEIERVVGPKLKKGYVYGGVSDMCFDGDAMEIGRLVGDVVFEFEKGVEIVIRKERVLADVGGGVHCVGIGRSERLGAASNIIGNFHQQNLWVEFDLANRRVGFGEADCSRSIN* 442
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Apr9g1295 441 MobiDBLite consensus disorder prediction 52 73 - -
Apr9g1295 441 Pfam Xylanase inhibitor N-terminal 85 239 IPR032861 -
Apr9g1295 441 PANTHER ASPARTYL PROTEASE-RELATED 11 439 IPR001461 GO:0004190|GO:0006508
Apr9g1295 441 SUPERFAMILY Acid proteases 85 439 IPR021109 -
Apr9g1295 441 Pfam Xylanase inhibitor C-terminal 276 432 IPR032799 -
Apr9g1295 441 Gene3D Acid Proteases 58 242 IPR021109 -
Apr9g1295 441 MobiDBLite consensus disorder prediction 50 73 - -
Apr9g1295 441 Gene3D Acid Proteases 244 440 IPR021109 -
Apr9g1295 441 CDD pepsin_A_like_plant 85 436 IPR034161 -
Apr9g1295 441 ProSitePatterns Eukaryotic and viral aspartyl proteases active site. 99 110 IPR001969 GO:0004190|GO:0006508
Apr9g1295 441 ProSiteProfiles Peptidase family A1 domain profile. 84 432 IPR033121 -
Apr9g1295 441 PANTHER EUKARYOTIC ASPARTYL PROTEASE FAMILY PROTEIN 11 439 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Apr9g1295 Apr-Chr9 22611062 22614755 Wgd
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Apr9g1295 52 438 Miscellaneous Gene Families AT1G44130 22.717 1.32e-18 85.5
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Apr9g1295 - - gmx:100790706 702.975
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Apr10g1988 10 32770428 32772964 Apr9g1295 9 22611062 22614755 PCT